Skip to content
★ Sign in to follow
EB

Essex Bio-Technology Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$1.2B

No insider purchase over the last 90 days. The latest, by YAU LAI MAN, was filed 20 Oct 2020.

Essex Bio-Technology Ltd.: what insiders have been doing

Essex Bio-Technology Ltd. is a listed company. Its insiders report their share dealings to HKEX. Nothing new has been filed by managers of Essex Bio-Technology Ltd. in twelve months, the latest record being from 10 January 2022.

Our records for Essex Bio-Technology Ltd. go back to 2018, with 4 purchases and 7 sales on the open market in total.

Elsewhere in the same market, our signals recently picked up insider purchases at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€195,563
4 ops. · all time
Sell Volume
€2M
7 ops. · all time

Since the insiders bought

  • Filed 20 Oct 2020 · 2210 days ago · €21k
    +26.5%
    Entry HK$4.37 · Close at T+365 HK$5.53
  • Filed 20 Aug 2019 · 2637 days ago · €74k
    -3.3%
    Entry HK$5.17 · Close at T+365 HK$5.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 385 of 26,897 companies
85.9
score / 100
Value
92
Quality
79
FCF yld11%
Earn yld27%
EV/EBITDA3.1x
ROE11%
Gross mgn89%
Net mgn18%
Debt/EBITDA0.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$2.09
Analyst consensus
1 analysts
·
HK$6.84Target HK$6.84(+228%)HK$6.84
Income statement
RevenueHK$1.8B
Gross profitHK$1.6B89% margin
EBITDAHK$485.1M27% margin
Net incomeHK$318.1M15.4% margin
Valuation
PER (trailing)4.4x
P/Book0.5x
Beta-0.01
Balance sheet & cash
Market capHK$1.2B
Total debtHK$346.9M
Free Cash FlowHK$131.7M
Debt / Equity14%
Profitability & ownership
ROE11.0%
ROA6.3%
% insiders54.3%
% institutions1.0%
Last declaration on 10 January 2022
Declarations16 total
  • ▼
    DirectorExecutives
    0HKEX
    1,000,000 sharesShareXHKGHKEX:DA20220110E00204
  • ▲
    DirectorExecutives
    192,841 HKD19HKEX
    46,000 shares@ HK$4.1922100.0% of flowShareXHKGHKEX:DA20201020E00449
    Canonical exit: 14 Jan 2021 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    3,039,000 sharesShareXHKGHKEX:DA20200922E00254
  • ●
    DirectorExecutives
    0HKEX
    2,036,150 sharesShareXHKGHKEX:DA20200706E00085
  • ▲
    DirectorExecutives
    640,445 HKD15HKEX
    126,000 shares@ HK$5.082942.3% of flowShareXHKGHKEX:DA20190820E00300
    Canonical exit: 17 Nov 2019 (T+90)
  • ▲
    DirectorExecutives
    454,203 HKD14HKEX
    90,000 shares@ HK$5.046729.8% of flowShareXHKGHKEX:DA20190816E00343
    Canonical exit: 12 Nov 2019 (T+90)
  • ▲
    DirectorExecutives
    424,712 HKD14HKEX
    84,000 shares@ HK$5.056128.0% of flowShareXHKGHKEX:DA20190816E00345
    Canonical exit: 13 Nov 2019 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    1,800,000 sharesShareXHKGHKEX:DA20181022E00376
  • ▼
    DirectorExecutives
    3M HKD12HKEX
    518,000 shares@ HK$5.1013.5% of flowShareXHKGHKEX:DA20181019E00476
  • ▼
    DirectorExecutives
    3M HKD13HKEX
    576,000 shares@ HK$5.2615.5% of flowShareXHKGHKEX:DA20181012E00332
  • ▼
    DirectorExecutives
    4M HKD13HKEX
    644,000 shares@ HK$5.9119.5% of flowShareXHKGHKEX:DA20181008E00369
  • ●
    DirectorExecutives
    0HKEX
    1,060,000 sharesShareXHKGHKEX:DA20180424E00436
  • ▼
    DirectorExecutives
    3M HKD13HKEX
    373,000 shares@ HK$8.8315.8% of flowShareXHKGHKEX:DA20180412E00335
  • ▼
    DirectorExecutives
    6M HKD14HKEX
    737,000 shares@ HK$8.4730.0% of flowShareXHKGHKEX:DA20180408E00002
  • ●
    DirectorExecutives
    0HKEX
    500,000 sharesShareXHKGHKEX:DA20180403E00303
  • ▼
    DirectorExecutives
    1M HKD12HKEX
    146,000 shares@ HK$8.205.7% of flowShareXHKGHKEX:DA20180329E00212

16 of 16 declarations

About Essex Bio-Technology Ltd.

Essex Bio-Technology Ltd. is a company focused on the development and manufacturing of biopharmaceutical products. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations